Introduction of Sysmex Sysmex Partec GmbH President & CEO - - PowerPoint PPT Presentation

▶

Aug 11, 2023 183 likes •357 views

Introduction of Sysmex Sysmex Partec GmbH President & CEO Shinjiro Akamatsu Sysmex Group Overview Outline Head Office Chuo-ku, Kobe, Japan Established February 20, 1968 Paid-in Capital JPY12,276 million Consolidated Sales JPY

SLIDE 1

Introduction of Sysmex

Sysmex Partec GmbH President & CEO Shinjiro Akamatsu

SLIDE 2

Sysmex Group Overview

SLIDE 3

Outline

Head Office Chuo-ku, Kobe, Japan Established February 20, 1968 Paid-in Capital JPY12,276 million Consolidated Sales JPY 281,935 million Subsidiaries and Affiliates 74 (Japan: 11 Overseas: 63) Number of Employees 8,445 (Japan: 3,517 Overseas: 4,928)

*including part-time employees

Main Lines of Business Development, manufacture, sales, import and export of diagnostics testing instruments and reagents, and related software Corporate name mean SYStematical MEdics ＋ X

As of the end of March 2018

SLIDE 4

History

4 FY1995 FY2017

Overseas affiliates:

5 63

Product exports:

90 countries Over 190 countries

Overseas sales ratio:

Approx. 45%

84.0%

Overseas employees:

Approx. 250 (20%)

4,928 (58.4%) 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 500 1,000 1,500 2,000 2,500 3,000 1968 1972 1976 1980 1984 1988 1992 1996 2000 2004 2008 2012 2016

Overseas sales Japan sales Number of Employees

2008: Established Technopark 1968: Established as a sales company for TOA ELECTRIC (presently TOA) 2007: Established the “Sysmex Way” 1978: Launched the corporate brand name “Sysmex” Global alliance 1995: Siemens / 1998: Roche 1998: Company name change, and head office relocation

(100 million yen)

1980: Sysmex Europe for customer support 1995: Sysmex Deutschland for direct sales 1991: Sysmex UK for direct sales 2013: Partnership w/Partec GmbH

SLIDE 5

Business Segments

： Own brand

○： Including other brands

Instruments Maintenance service Reagents

Sales ratio by business

62.0% 7.3% 5.2% 16.0% 3.2% 6.3% Net Sales \ 281.9 billion 2018.3 F.Y.

Hematology
Others
Hemostasis
Imm./

Chem.

Urinalysis
Life Science

Business Production

Instruments Reagents

Hematology

Urinalysis
Immunochemistry
Clinical Chemistry

○

Hemostasis
○

Life Science

Others

SLIDE 6

Positioning

Ranked in global top 10 as the only Asian based company

*Sysmex estimates as of May 2018

Clinical Chemistry Immuno- chemisry Urinalysis

(Urine sediment)

Hemostasis Hematology 1st: Sysmex

2nd: Danaher (USA)

(Beckman Coulter)

3rd: Siemens (Germany)

In Vitro Diagnostics

1st: Sysmex

+ Siemens (Germany) 2nd: IL (Spain) 3rd: Stago (France)

1st: Sysmex

2nd: Danaher (USA)

(Iris)

Market Share Sysmex Others Hema- tology

*Sysmex estimate as of March 2016

1st： Roche (Switz.) 2nd： Danaher (USA) 3rd： Siemens (Germany) ・・・・

7th: Sysmex

*Sysmex estimate as of May 2018

SLIDE 7

Network (Global)

Sysmex Corporation （日本） Japan 16.0% Americas 23.5% EMEA 26.2% China 25.6% AP 8.8%

Sales ratio by region

2018.3 F.Y.

 Export to more than 190 countries  63 overseas affiliates  84.0% of sales made in overseas markets

*As of the end of March 2018 Sysmex Shanghai Ltd. Sysmex Asia Pacific Pte Ltd. Sysmex Europe GmbH Sysmex America, Inc.

SLIDE 8

Production Bases

 Instruments production base: 4 base in Japan & 1 in Germany  Reagents production bases: 2 bases in Japan, 8 bases in overseas

Brazil Germany

Japan

USA Singapore China India

SLIDE 9

Strategy together with Partec GmbH

SLIDE 10

Introduction of Sysmex Partec GmbH (SPG)

SLIDE 11

Overview

 Established in 1967  Joined Sysmex group in September, 2013  Headquarters: Görlitz, Germany  4 facilities in Germany (2 in Görlitz, 1 in Münster, 1 in Leipzig)  Headcount: 175 *as of July 2018  Certification: ISO9001:2015, ISO13485:2016 CE-IVD for IVD products, CE mark for non-IVD products WHO-Prequalification for CD4 solutions

SLIDE 12

Facilities

Münster (21) Leipzig (7) Görlitz (147) ( ): Head count # Flugplatz (13) Arndtstrasse (134)

4 facilities in Germany
Münster: Customer facing function
Saxon area: Back office

SLIDE 13

SPG Products Overview

EHC (Essential Health Care) R&I-FCM (Research & Industrial FCM)

CyFlow Cube 6 CyFlow Space CyFlow Cube8 CyFlow PA CyFlow Counter Reagents Reagents & Consumables

SLIDE 14

Advantages of SPG

Development Optics technology Connection with researchers especially in EU region Support / funding by public organization Bio-cluster network in Saxon Production Precision machining and assembly by Meister Easy access to suppliers by good location at the middle of west and east Europe Support / funding by public organization

SLIDE 15